4.4 Article

The significance of PTV dose coverage on cancer control outcomes in early stage non-small cell lung cancer patients treated with highly ablative stereotactic body radiation therapy

Related references

Note: Only part of the references are listed.
Article Otorhinolaryngology

Long-term experience with reduced planning target volume margins and intensity-modulated radiotherapy with daily image-guidance for head and neck cancer

Allen M. Chen et al.

HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK (2014)

Article Medicine, General & Internal

Stereotactic Body Radiation Therapy for Inoperable Early Stage Lung Cancer

Robert Timmerman et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2010)

Article Cardiac & Cardiovascular Systems

Stereotactic body radiation therapy versus surgical resection for stage I non-small cell lung cancer

Traves D. Crabtree et al.

JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY (2010)

Article Engineering, Biomedical

Experimental verification of a commercial Monte Carlo-based dose calculation module for high-energy photon beams

Thomas Kuenzler et al.

PHYSICS IN MEDICINE AND BIOLOGY (2009)

Article Radiology, Nuclear Medicine & Medical Imaging

Efficient particle transport simulation through beam modulating devices for Monte Carlo treatment planning

M Fippel

MEDICAL PHYSICS (2004)